Yi-Wen Hsieh

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Vascular Endothelial Growth Factor

Optical Coherence Tomography

Coronary Artery Bypass Grafting

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Teena Bhakuni, Pieter R Norden, Naoto Ujiie, Can Tan, Sun Kyong Lee, Thomas Tedeschi, Yi-Wen Hsieh, Ying Wang, Ting Liu, Amani A Fawzi, Tsutomu Kume
FOXC1 regulates endothelial CD98 (LAT1/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation. Nature communications 15 (1) (2024)
Teena Bhakuni, Pieter R Norden, Naoto Ujiie, Can Tan, Sun Kyong Lee, Thomas Tedeschi, Yi-Wen Hsieh, Ying Wang, Ting Liu, Amani A Fawzi, Tsutomu Kume
FOXC1 regulates endothelial CD98 (LAT1/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation. Nature communications 15 (1) (2024)
Teena Bhakuni, Pieter R Norden, Naoto Ujiie, Can Tan, Sun Kyong Lee, Thomas Tedeschi, Yi-Wen Hsieh, Ying Wang, Ting Liu, Amani A Fawzi, Tsutomu Kume
FOXC1 regulates endothelial CD98 (LAT1/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation. Nature communications 15 (1) (2024)
Teena Bhakuni, Pieter R Norden, Naoto Ujiie, Can Tan, Sun Kyong Lee, Thomas Tedeschi, Yi-Wen Hsieh, Ying Wang, Ting Liu, Amani A Fawzi, Tsutomu Kume
FOXC1 regulates endothelial CD98 (LAT1/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation. Nature communications 15 (1) (2024)
Teena Bhakuni, Pieter R Norden, Naoto Ujiie, Can Tan, Sun Kyong Lee, Thomas Tedeschi, Yi-Wen Hsieh, Ying Wang, Ting Liu, Amani A Fawzi, Tsutomu Kume
FOXC1 regulates endothelial CD98 (LAT1/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation. Nature communications 15 (1) (2024)
Katia Corano Scheri, Yi-Wen Hsieh, Eunji Jeong, Amani A Fawzi
Limited Hyperoxia-Induced Proliferative Retinopathy (LHIPR) as a Model of Retinal Fibrosis, Angiogenesis, and Inflammation. Cells 12 (20) (2023)